SNDK TECHNICALS

I was just reviewing the IBD 100 list and this stock stuck out. The stock peaked in January and has now apparently "bottomed" in the 55 area. What strikes me on the chart is that the MACD histogram bottomed in mid February when the price was higher. So the price is lower but the momentum indicators are higher. That is a positive divergence indicating the stock is probably now a good buy. It is also interesting that after plummeting 30% from its high, the stock still has an IBD RS rating of 90. The EPS rating never fell and is still at 98. Certaintly one worth investigating.